HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphorylase ratio and susceptibility to malignant hyperthermia.

Abstract
The ratio of muscle phosphorylase a to total phosphorylase, expressed as a percent, was determined in vastus lateralis muscle of 26 patients to examine the efficacy of this parameter as a method for screening for susceptibility to malignant hyperthermia (MH). As standard screening, all patients also had muscle contracture responses determined to 2% halothane and 0.25-32 mM caffeine at 37 degrees C. Each drug was given separately and not combined. Nine patients were susceptible to MH, based upon caffeine threshold of 2 mM or less (seven patients) or a rapidly developing contracture tension to halothane of more than 400 mg (seven patients, including five with positive caffeine responses). Mean phosphorylase ratio in these nine patients was 14.5 +/- 2.0% (mean, SEM). In the 17 nonsusceptible patients mean phosphorylase ratio (12.4 +/- 1.9%) was not significantly different. The range of phosphorylase ratios in susceptible patients was 6.5-26% while 13 nonsusceptible patients had ratios greater than 6% and up to 29%. The unacceptably high number of false-positive responses in nonsusceptible patients precludes the use of phosphorylase ratio as a definitive diagnostic test.
AuthorsC A Traynor, R A Van Dyke, G A Gronert
JournalAnesthesia and analgesia (Anesth Analg) Vol. 62 Issue 3 Pg. 324-6 (Mar 1983) ISSN: 0003-2999 [Print] United States
PMID6299136 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Caffeine
  • Phosphorylase a
  • Phosphorylases
  • Phosphotransferases
Topics
  • Adolescent
  • Adult
  • Caffeine (pharmacology)
  • Clinical Enzyme Tests
  • Female
  • Humans
  • In Vitro Techniques
  • Male
  • Malignant Hyperthermia (diagnosis, etiology)
  • Muscle Contraction (drug effects)
  • Muscles (enzymology)
  • Phosphorylase a (metabolism)
  • Phosphorylases (metabolism)
  • Phosphorylation
  • Phosphotransferases (metabolism)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: